Merck shutters French research site in a reorganization aimed at eliminating more than 200 jobs
Merck is shuttering a toxicology research center in central France and scaling back on its manufacturing operations in the area, laying off more than 200 staffers in the process.
La Montagne reported that the move will eliminate 106 research jobs, with more than 100 manufacturing positions on the chopping block as well.
According to Merck, the production facilities have been underutilized and it’s been running a smaller and smaller number of tox studies at the site, leading to the plans to wind down operations. The pharma player is looking for a buyer to carry on the manufacturing effort.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 67,600+ biopharma pros reading Endpoints daily — and it's free.